FDA.reportPublic FDA data

Application 212367

Type
ANDA
Sponsor
PERRIGO UK FINCO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATEBETAMETHASONE DIPROPIONATE; CALCIPOTRIENESUSPENSION;TOPICAL0.064%;0.005%NoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionatePadagis Israel Pharmaceuticals LtdANDACurrent
45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionatePadagis Israel Pharmaceuticals LtdANDACurrent
45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionatePerrigo New York IncANDACurrent
63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionateBryant Ranch PrepackANDACurrent
63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionateBryant Ranch PrepackANDACurrent
63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionateBryant Ranch PrepackANDACurrent
63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionateBryant Ranch PrepackANDACurrent
63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionateBryant Ranch PrepackANDACurrent
63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionateBryant Ranch PrepackANDACurrent